|
Glenmark Pharmaceuticals Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
52540.15 Cr.
|
P/BV
|
6.22
|
Book Value (Rs.)
|
299.28
|
|
52 Week High/Low (Rs.)
|
1843/1272
|
FV/ML
|
1/1
|
P/E(X)
|
50.18
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
37.10
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 3220.13 | 3301.90 | 3400.50 | 3223.30 | 3062.95 |
| Other Operating Income | 36.07 | 85.65 | 33.30 | 20.88 | 0.00 |
| Total Income From Operations | 3256.21 | 3387.55 | 3433.80 | 3244.19 | 3062.95 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 794.78 | 746.37 | 774.36 | 685.77 | 754.31 |
| Purchase of Traded Goods | 344.74 | 418.15 | 443.08 | 360.03 | 210.80 |
| Increase/Decrease in Stocks | -50.57 | -80.28 | -147.36 | 64.28 | 30.42 |
| Employees Cost | 736.57 | 788.49 | 786.57 | 710.44 | 700.96 |
| Depreciation | 125.21 | 122.74 | 120.28 | 117.79 | 151.34 |
| Other Expenses | 869.66 | 914.60 | 975.24 | 835.45 | 862.13 |
| Total Expenses | 2820.39 | 2910.06 | 2952.16 | 2773.76 | 2709.95 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 435.82 | 477.49 | 481.63 | 470.42 | 353.01 |
| Other Income | 11.69 | 31.13 | 39.42 | 31.49 | 773.17 |
| P/L Before Interest, Excpt. Items & Tax | 447.51 | 508.62 | 521.05 | 501.92 | 1126.17 |
| Interest | 66.71 | 52.29 | 48.48 | 39.58 | 148.56 |
| P/L Before Exceptional Items & Tax | 380.79 | 456.33 | 472.57 | 462.33 | 977.61 |
| Exceptional Items | -372.82 | 0.00 | 0.00 | 0.00 | -446.78 |
| P/L Before Tax | 7.97 | 456.33 | 472.57 | 462.33 | 530.83 |
| Tax | 3.59 | 108.30 | 118.09 | 122.10 | 1769.47 |
| P/L After Tax from Ordinary Activities | 4.38 | 348.03 | 354.49 | 340.24 | -1238.65 |
| Extra Ordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 24.38 |
| Net Profit/Loss For the Period | 4.38 | 348.03 | 354.49 | 340.24 | -1214.27 |
| Minority Interest | 0.27 | -0.07 | -0.27 | 0.03 | -4.01 |
| Net P/L After Minority Interest & Share Of Associates | 4.65 | 347.96 | 354.21 | 340.27 | -1218.28 |
| | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.16 | 12.33 | 12.55 | 12.06 | -43.18 |
| Diluted EPS (Rs.) | 0.16 | 12.33 | 12.55 | 12.06 | -43.18 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.16 | 12.33 | 12.55 | 12.06 | -43.18 |
| Diluted EPS (Rs.) | 0.16 | 12.33 | 12.55 | 12.06 | -43.18 |
| | | | | | |
| PBITOE Margin (%) | 13.38 | 14.09 | 14.02 | 14.50 | 11.52 |
| PBTE Margin (%) | 11.69 | 13.47 | 13.76 | 14.25 | 31.91 |
| PBT Margin (%) | 0.24 | 13.47 | 13.76 | 14.25 | 17.33 |
| PAT Margin (%) | 0.13 | 10.27 | 10.32 | 10.48 | -39.64 |
| PAT After MI And SOA Margin (%) | 0.14 | 10.27 | 10.31 | 10.48 | -39.77 |
